The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
Active, not recruiting · NCT03140358 · Registry updated 2025-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3) | eye disorder, myopia, refractive error | Active, not recruiting | Phase 3 | 2025-05-18 | NCT03140358 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Medical Research Council (NMRC), Singapore | 19 |
| Singapore National Eye Centre | 21 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Singapore eye research institute | Singapore | Singapore | 1 |